154 related articles for article (PubMed ID: 22795047)
1. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
[TBL] [Abstract][Full Text] [Related]
2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
3. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
[TBL] [Abstract][Full Text] [Related]
4. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
5. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
6. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
7. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
[TBL] [Abstract][Full Text] [Related]
8. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
9. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
10. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
11. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.
Baune BT; Dannlowski U; Domschke K; Janssen DG; Jordan MA; Ohrmann P; Bauer J; Biros E; Arolt V; Kugel H; Baxter AG; Suslow T
Biol Psychiatry; 2010 Mar; 67(6):543-9. PubMed ID: 20044070
[TBL] [Abstract][Full Text] [Related]
12. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
[TBL] [Abstract][Full Text] [Related]
13. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
[TBL] [Abstract][Full Text] [Related]
14. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
16. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
Lee SH; Lee KJ; Lee HJ; Ham BJ; Ryu SH; Lee MS
Psychiatry Clin Neurosci; 2005 Apr; 59(2):140-5. PubMed ID: 15823158
[TBL] [Abstract][Full Text] [Related]
17. Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Psychopharmacol; 2015 May; 29(5):615-22. PubMed ID: 25294870
[TBL] [Abstract][Full Text] [Related]
18. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
[TBL] [Abstract][Full Text] [Related]
19. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
[TBL] [Abstract][Full Text] [Related]
20. The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Neural Transm (Vienna); 2015 Jan; 122(1):59-68. PubMed ID: 25448875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
